Literature DB >> 4580860

Keynote address on biostatistics and data retrieval.

M Zelen.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4580860

Source DB:  PubMed          Journal:  Cancer Chemother Rep 3        ISSN: 0069-0139


× No keyword cloud information.
  101 in total

1.  Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation.

Authors:  Abraham J Wu; Andrea Gillis; Amanda Foster; Kaitlin Woo; Zhigang Zhang; Daphna Y Gelblum; Robert J Downey; Kenneth E Rosenzweig; Leonard Ong; Carmen A Perez; M Catherine Pietanza; Lee Krug; Charles M Rudin; Andreas Rimner
Journal:  Radiother Oncol       Date:  2017-08-01       Impact factor: 6.280

2.  Economic and quality-of-life aspects of treating small cell lung cancer.

Authors:  P Graham; J Boyages
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

3.  Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.

Authors:  Tomomi Nobashi; Sho Koyasu; Yuji Nakamoto; Takeshi Kubo; Takayoshi Ishimori; Young H Kim; Akihiko Yoshizawa; Kaori Togashi
Journal:  Br J Radiol       Date:  2016-01-12       Impact factor: 3.039

4.  Limited disease of extra-pulmonary small cell carcinoma. Impact of local treatment and nodal status, role of cranial irradiation.

Authors:  A C Müller; C Gani; M Weinmann; F Mayer; B Sipos; M Bamberg; F Eckert
Journal:  Strahlenther Onkol       Date:  2012-03       Impact factor: 3.621

Review 5.  [Updated strategies in Small Cell Lung Cancer post ASCO 2007].

Authors:  Stefan Hoschek; Ursula Hoschek-Risslegger; Michael Fiegl; August Zabernigg; Georg Pall; Thomas Auberger; Eberhard Gunsilius; Thomas Schmid; Herbert Jamnig; Wolfgang Hilbe
Journal:  Wien Med Wochenschr       Date:  2007

6.  E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer.

Authors:  Taofeek K Owonikoko; Joseph Aisner; Xin Victoria Wang; Suzanne E Dahlberg; Eric H Rubin; Suresh S Ramalingam; Murugesan Gounder; Paul Gregory Rausch; Rita S Axelrod; Joan H Schiller
Journal:  Cancer Chemother Pharmacol       Date:  2013-11-28       Impact factor: 3.333

7.  Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.

Authors:  Denise Bernhardt; Sebastian Adeberg; Farastuk Bozorgmehr; Nils Opfermann; Juliane Hoerner-Rieber; Laila König; Jutta Kappes; Michael Thomas; Felix Herth; Claus Peter Heußel; Arne Warth; Jürgen Debus; Martin Steins; Stefan Rieken
Journal:  J Neurooncol       Date:  2017-05-30       Impact factor: 4.130

8.  [Small cell lung cancer: pathology and molecular pathology].

Authors:  K Junker; I Petersen
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

Review 9.  Treatment for small cell lung cancer, where are we now?-a review.

Authors:  Gabriela Alvarado-Luna; Daniela Morales-Espinosa
Journal:  Transl Lung Cancer Res       Date:  2016-02

Review 10.  The clinical utility of circulating tumour cells in patients with small cell lung cancer.

Authors:  Victoria Foy; Fabiola Fernandez-Gutierrez; Corinne Faivre-Finn; Caroline Dive; Fiona Blackhall
Journal:  Transl Lung Cancer Res       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.